Filter
2372
Filtered Results: 2372
Text search:
human
diversity
Featured
Recommendations
158
New Publications
614
Language
Document type
No document type
1309
Studies & Reports
535
Guidelines
198
Manuals
130
Strategic & Response Plan
108
Training Material
37
Fact sheets
26
Situation Updates
16
Resource Platforms
6
Infographics
3
Brochures
2
App
1
Videos
1
Countries / Regions
Global
116
Kenya
63
Myanmar / Burma
56
Ethiopia
51
Nepal
51
India
48
Bangladesh
43
Sierra Leone
42
Western and Central Europe
42
Syria
41
Latin America and the Carribbean
38
South Africa
36
Africa
35
Nigeria
34
Uganda
34
Zambia
29
Rwanda
27
Malawi
27
Congo, Democratic Republic of
23
Liberia
22
South Sudan
21
Germany
21
Namibia
19
Philippines
17
Indonesia
17
South–East Asia Region
17
Ghana
16
Ukraine
15
East and Southern Africa
15
Yemen
14
Venezuela
14
Asia
13
Lebanon
12
Lesotho
12
Zimbabwe
11
Tanzania
11
Cambodia
10
Mozambique
10
Colombia
10
Eastern Europe
10
Guinea
9
Haiti
9
Jordan
9
Sudan
9
Botswana
9
Middle East and North Africa
9
Cameroon
8
Central African Republic
8
West and Central Africa
8
Burkina Faso
7
Senegal
7
Afghanistan
7
Eswatini/ Swaziland
7
Laos
7
Brazil
6
Eastern Europe and Central Asia
6
Russia
6
Thailand
5
Paraguay
5
Albania
5
Somalia
4
Pakistan
4
Iraq
4
Western Pacific Region
4
Palestine
4
Vietnam
4
Mali
3
USA
3
Turkey
3
China
3
Papua New Guinea
3
Peru
3
Libya
3
Southern Africa
3
Moldova
3
Iran
3
Guinea-Bissau
2
Saudi Arabia
2
Egypt
2
Ecuador
2
Angola
2
Madagascar
2
Mexico
2
Sri Lanka
2
Canada
2
Tajikistan
2
Georgia
2
Mauritius
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Chad
1
Malaysia
1
Ireland
1
Singapore
1
Benin
1
Switzerland
1
Burundi
1
Honduras
1
Bolivia
1
Greece
1
Guatemala
1
Chile
1
Fiji
1
Italy
1
Armenia
1
Timor Leste/ East Timor
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
724
Public Health
139
Key Resources
119
Women & Child Health
114
Clinical Guidelines
94
Capacity Building
28
Pharmacy & Technologies
9
Annual Report MEDBOX
1
Toolboxes
Disability
234
Mental Health
214
Planetary Health
214
HIV
207
COVID-19
138
Conflict
93
Refugee
80
Global Health Education
77
Caregiver
54
TB
53
AMR
53
NTDs
53
Rapid Response
47
Natural Hazards
42
Social Ethics
38
Ebola
33
Health Financing Toolbox
20
NCDs
20
Pharmacy
15
Specific Hazards
9
Polio
7
Cholera
5
Zika
3
South Sudan
1
Typhoon
1
The Manifesto to Secure a Healthy Planet for All – A Call for Emergency Action | InterAction Council
The Manifesto was launched at a High Level Event in London on the 31st July 2019, where Emergency response mechanisms to address the Climate and Environmental Crisis are being explored. The Manifesto has been developed in response to the increasing international and United Nations evidence and under...
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the ...-animal-environmental interface. The recognition that many risk drivers of infectious disease fall outside of the typical domain of the health sector creates the challenge of identifying and pursuing priorities for cross-sectoral action aimed at strengthening global health security. In response, the One Health concept has emerged, as have related initiatives addressing Planetary Health and Biodiversity and Human Health. From a public health perspective and operationally speaking, the One Health approach offers great potential, emphasising as it does cooperation and coordination between multiple sectors. Yet despite having been a focal point for discussion for over a decade, numerous challenges facing the implementation of One Health preparedness strategies remain. While some are technical, related to the requirement for innovative early warning systems or new vaccines, for example, others are institutional and cultural in nature, given the transdisciplinary nature of the topic. There have thus been calls to address One Health from multiple perspectives, from ecology to the social sciences. In order to further explore this issue and to identify priority areas for action for strengthening One Health preparedness in Europe, ECDC convened an expert consultation on 11–12 December 2017.
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics...
The escalation of the war in Ukraine began on 24 February 2022, causing thousands of civilian
casualties; destroying civilian infrastructure, including hospitals, and triggering the fastest-
growing displacement crisis in Europe since World War II. The demographic profile of Ukraine,
combined wit...
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of ... Chagas disease, particularly the severe cardiac form, is available in the literature. However, information concerning events during the acute phase of the disease is scarce. In this review, we will discuss the current status of acute Chagas disease cases globally, the immunological findings related to the acute phase and their possible influence in disease outcome, and reactivation of Chagas disease in immunocompromised individuals, a key point for transplantation and HIV invection management.
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, serving as a rationale to the related actions of the Working for Health progression model (see Annex). The brief aims to inform Member States, non-state actors and other users of the Action Plan to guide action on inves...
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, providing a rationale for the related actions of the Working for Health progression model (see Annex). This brief aims to inform Member States, non-state actors and other stakeholders vested in implementing the Action ...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
This Urban Flood Risk Handbook: Assessing Risk and Identifying Interventions is a roadmap for conducting an urban flood risk assessment in any city in the world. It includes practical guidance for a flood risk assessment project, covering the key hazard and risk modeling stages as well as the evalua...
In October 2022, President Biden signed the Global Malnutrition Prevention and Treatment Act (GMPTA) into law, which directs USAID to prevent and treat malnutrition globally. The GMPTA further codifies USAID’s leadership on nutrition, with a focus on evidence-based interventions across health syst...
This document contains guidance for strengthening the disability inclusiveness of MHPSS responses and programmes in emergency settings. It is intended to supplement the IASC Guidelines on Mental Health and Psychosocial Support in Emergency Settings (2007).
Overall Objective
To consider and add...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ...
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial globa...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first ... case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
